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Abstract
Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme, is essential 
for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol, and fatty acids with an 
odd number of carbon atoms. Deficiencies of PCC activity in humans are linked to the disease 
propionic acidemia (PA), an autosomal recessive disorder that can be fatal in infants 1–4. The 
holoenzyme of PCC is an α6β6 dodecamer, with a molecular weight of 750 kD. The α subunit 
contains the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains, while 
the β subunit supplies the carboxyltransferase (CT) activity. Here we report the crystal structure at 
3.2 Å resolution of a bacterial PCC α6β6 holoenzyme as well as cryo-electron microscopy (cryo-
EM) reconstructionat 15 Å resolution demonstrating a similar structure for human PCC. The 
structure defines the overall architecture of PCC and reveals unexpectedly that the α subunits are 
arranged as monomers in the holoenzyme, decorating a central β6 hexamer. A hitherto 
unrecognized domain in the α subunit, formed by residues between the BC and BCCP domains, is 
crucial for interactions with the β subunit. We have named it the BT domain. The structure reveals 
for the first time the relative positions of the BC and CT active sites in the holoenzyme. They are 
separated by approximately 55 Å, indicating that the entire BCCP domain must translocate during 
catalysis. The BCCP domain is located in the active site of the β subunit in the current structure, 
providing insight for its involvement in the CT reaction. The structural information establishes a 
molecular basis for understanding the large collection of disease-causing mutations in PCC, and 
also has important relevance for the holoenzymes of other biotin-dependent carboxylases, 
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including 3-methylcrotonyl-CoA carboxylase (MCC) 5–7 and eukaryotic acetyl-CoA carboxylase 
(ACC) 8,9.
Keywords
fatty acid metabolism; amino acid metabolism; propionic acidemia; 3-methylcrotonylglycinuria; 
protein complex; biotin-dependent carboxylase; acetyl-CoA carboxylase; 3-methylcrotonyl-CoA 
carboxylase
PCCs catalyze the carboxylation of propionyl-CoA to produce D-methylmalonyl-CoA. 
These enzymes are found from bacteria to humans, with highly conserved amino acid 
sequences. For example, the α and β subunits of human PCC (HsPCC) and Ruegeria 
pomeroyi PCC (RpPCC) share 54% and 65% sequence identity, respectively 
(Supplementary Figs. 1, 2). To simplify discussions, we have numbered residues in bacterial 
PCCs according to their equivalents in HsPCC. The BC and BCCP domains in the α subunit 
are homologous to their equivalents in ACC and pyruvate carboxylase (PC), while the β 
subunit is homologous to the CT domain of ACC. The active site of BC is formed by 
residues from its A and C (sub-)domains, while the B (sub-)domain forms a lid that can 
assume open and closed conformations 9–11. The active site of CT is located at the interface 
of its dimer, and each CT contains two (sub-)domains, N and C domains 9,12. In contrast to 
the wealth of information about these domains, little is known about how they are assembled 
into the holoenzyme of PCC (or ACC).
After extensive efforts (Supplementary text), we determined the crystal structure of a PCC 
chimera, containing the α subunit of RpPCC and the β subunit of Roseobacter denitrificans 
PCC (RdPCC) (Supplementary Table 1). The structure of the chimera is essentially the same 
as that of the native RpPCC dodecamer (Supplementary text) as well as that of the HsPCC 
holoenzyme (see below).
The structure of the α6β6 PCC holoenzyme contains a central β6 hexamer core, in the shape 
of a short cylinder with a small hole along its axis (Fig. 1a). This hexameric core can be 
considered as a trimer of β2 dimers, with each dimer being formed by one subunit from each 
layer of the structure (Fig. 1b). In contrast, the α subunits are arranged as monomers on both 
ends of the β6 core, far from the center of the holoenzyme, with each α subunit contacting 
primarily only one β subunit (see below). There are no significant conformational 
differences among the six copies of the α and β subunits of the holoenzyme (Supplementary 
text).
We carried out cryo-EM studies on HsPCC and obtained a 3D reconstruction at 15 Å 
resolution by single particle analysis (Supplementary Figs. 3–6). The cryo-EM envelope is 
remarkably similar to the overall shape of the crystal structure (Fig. 1c). In fact, the atomic 
model can be readily fit into the cryo-EM map, giving a cross-correlation value of 0.80, and 
only the BCCP domain appears to be in a somewhat different position (Fig. 1d). These 
studies demonstrate that the structure of HsPCC is highly similar to that of the bacterial 
enzyme.
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An unexpected discovery from the crystal structure of the holoenzyme is that there is little 
direct contact between the BC domain in the α subunit and the β subunit (Fig. 2a). Instead, 
interactions with the β subunit are primarily mediated by a hitherto unrecognized domain in 
the α subunit, formed by residues 514–653 in the connection between the BC and BCCP 
domains (Supplementary Fig. 1). We have named it the BT domain, as it mediates BC-CT 
interactions. The BT domain has well-defined electron density (Supplementary Fig. 7), 
suggesting that it is highly ordered in the holoenzyme. A total of 1,950 Å2 of the surface 
area of each α subunit is buried at the interface with the β subunits. Only 200 Å2 are 
contributed by the BC domain (Fig. 2a). In contrast, the BT domain contributes 1,300 Å2 to 
the buried surface area with one β subunit, and an additional 100 Å2 with an adjacent β 
subunit (Fig. 2a). Finally, the BCCP domain contributes 350 Å2 to the interface (see below).
The BT domain contains a long helix (αV, Supplementary Fig. 1) at the N-terminus, 
followed by an eight-stranded up-down β-barrel (β22-β29) that surrounds the N-terminal 
two-thirds of the helix (Fig. 2a, Supplementary Fig. 8). The C-terminal one-third of the helix 
and the long loop connecting to the first β-strand protrude from the βbarrel, and form a 
‘hook’ that provides a major contact with the β subunit (Fig. 2b, Supplementary Fig. 8). A 
second area of close contact with the β subunit is mediated by a small helix (αW) at the end 
of the BT domain (Fig. 2c, Supplementary Fig. 8), which projects away from the β-barrel 
(Fig. 2a). The BT domain does not have any close structural homologs in the Protein Data 
Bank, based on an analysis with the program DaliLite 13. Remarkably, however, the domain 
does share some structural similarity with the PT domain of PC, which helps mediate the 
tetramerization of that enzyme (Supplementary text, Supplementary Fig. 9) 14.
A large number of residues are located in the interface between the α and β subunits 
(Supplementary Figs. 1 and 2), forming ion-pair, hydrogen-bonding and hydrophobic 
interactions (Supplementary text). Residues making important contributions to the interface 
are generally conserved or show conservative variations among the PCC enzymes 
(Supplementary Figs. 1 and 2), consistent with our observations that HsPCC has a similar 
structure. Our mutagenesis data confirm the extensive nature of the α-β subunit interface and 
suggest that the holoenzyme can withstand substantial disruptions in it (Supplementary text, 
Supplementary Table 2).
Another unexpected discovery from the structure is that the BC domains are arranged as 
monomers in the PCC holoenzyme (Fig. 1a). Studies of the BC subunit of bacterial ACCs 
have shown a dimeric association 9–11, which may be required for its activity 15, although 
monomeric BC mutants are catalytically active 16. A conserved dimeric association of the 
BC domain was also observed in PC 14,17. However, the BC domains in PCC are 
monomeric and, in fact, there are no contacts among the α subunits in the holoenzyme (Fig. 
1a). Our structure defines the molecular basis for the lack of dimerization of the BC domain 
in PCC (Supplementary text). A monomeric arrangement of the BC domains also has 
significant relevance for the holoenzyme of eukaryotic ACCs (see below).
The active site of the BC domain is conserved with that of E. coli BC, and all the residues 
that interact with the substrates of this reaction have essentially the same conformation in 
both structures (Supplementary Fig. 10) 18. Similarly, residues in the active site of CT, 
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located at the interface of a β subunit dimer (Fig. 3a), are also conserved. The structure of 
this dimer is homologous to those of the S. coelicolor and M. tuberculosis acyl-CoA 
carboxylase β subunits 19,20 and the 12S subunit of P. shermanii transcarboxylase 
(Supplementary Fig. 11) 21, which also form similar hexamers. Weaker structural similarity 
is observed with the CT domain of yeast ACC12, the CT subunit of bacterial ACC 22, and 
the CT subunit of a bacterial sodium pump23, although these CT enzymes only form dimers. 
A helical sub-domain at the C-terminus of the CT domain of ACC is incompatible with the 
β6 hexamer of PCC.
Our structure reveals for the first time the relative positions of the BC and CT active sites in 
the holoenzyme, providing unprecedented insight into PCC catalysis. The distance between 
the two active sites in PCC is about 55 Å (Fig. 3a), and consequently the entire BCCP 
domain must translocate during catalysis (Supplementary text, Supplementary Fig. 12). A 
similar situation has been observed in the structure of PC, where the BC and CT active sites 
are separated by 75 Å 14,17. Our cryo-EM studies on HsPCC have provided direct 
experimental evidence that the BCCP domain can be located in different positions in the 
holoenzyme (Fig. 1d). Residues 654–660, the linker between the BT and BCCP domains, 
have weak electron density and are exposed to the solvent in the current structure (Fig. 1b), 
suggesting that they are flexible and can facilitate the translocation.
Further insight into PCC catalysis is obtained from the binding of the BCCP domain and its 
associated biotin, with well-defined electron density (Supplementary Fig. 13), in the CT 
active site (Fig. 3a). The interface between BCCP and the β subunit is small, with 350 Å2 
surface area burial. Only residues 693–697 around the biotinylation site (Lys694) interact 
with the β subunit, through hydrophobic interactions and one hydrogen bond (Fig. 3b, 
Supplementary Fig. 14). This weak interaction should also help the BCCP domain to leave 
the CT active site and translocate to the BC active site during catalysis.
The active site of CT is located in a deep canyon at the β subunit dimer interface (Fig. 3c). 
The α6 helix from the C domain of one subunit and the α6 helix from the N domain of the 
other subunit form the two walls of the canyon. Our structure shows that BCCP-biotin 
occupies one half of the canyon, interacting with the C domain of one subunit (Fig. 3d, 
Supplementary Fig. 14). Propionyl-CoA, the other substrate of this activity, is expected to 
occupy the other half of the canyon and interact with the N domain of the second β subunit 
(Fig. 3d) 12,19,21, with the propionyl group located in the center of the canyon (Fig. 3c). 
Biotin is in a partially folded, unproductive conformation in the current structure (Fig. 3b), 
although a conformational change in the side chain of Lys694 and the valeryl group of biotin 
should readily bring the N1′ atom into the proximity of propionyl-CoA for catalysis.
The structure of the holoenzyme establishes a foundation for understanding the molecular 
basis of the large number of disease-causing mutations in PCC (Fig. 4, Supplementary Table 
3) 1–4. Among these, only the R399Q mutation in the α subunit directly disrupts a residue in 
the active site (Supplementary Fig. 15). This side chain stabilizes the biotin enolate during 




. Another mutation, G668R in the BCCP domain (Fig. 4), abolishes biotinylation. Many 
of the other mutations are detrimental to catalysis by destabilizing the enzyme and/or 
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interfering with holoenzyme assembly 1,25–27. A large number of them, especially those in 
the β subunit, are actually located near the active site (Supplementary Fig. 15), and they may 
indirectly affect substrate binding and/or catalysis as well. For example, the R165W and 
R165Q mutations may disturb the recognition of the adenine base of CoA (Supplementary 
Fig. 15). On the other hand, few of the missense mutations are located in the interface 
between the α and β subunits of the holoenzyme (Fig. 4, Supplementary 16). The extensive 
nature of this interface makes it difficult to disrupt the holoenzyme by single-site mutations 
in this region (Supplementary text).
The structure of the PCC holoenzyme also has strong implications for the structure and 
function of other biotin-dependent carboxylases. There are five such enzymes in humans: 
PCC, MCC, ACC1, ACC2 and PC (Supplementary Fig. 17). MCC is a close homolog of 
PCC, with the same domain architecture and subunit organization. Therefore, the PCC 
structure is directly relevant for understanding the MCC enzyme and its disease-causing 
mutations 5–7.
Most importantly, the identification of the BT domain in PCC led us to reexamine the 
sequences of eukaryotic, multi-domain ACCs. The segment containing the BC and BCCP 
domains in these enzymes is remarkably similar to the PCC α subunit, with a linker of about 
120 residues between the two domains (Supplementary Fig. 17). Secondary structure 
prediction shows that this linker contains a helix followed by seven or more β-strands, 
suggesting that it may form a structure similar to the BT domain in PCC. This putative BT 
domain of ACC is likely also crucial for mediating interactions between its BC and CT 
domains. In fact, we have observed that purified BC and CT domains of yeast ACC do not 
interact with each other (unpublished results). Since the CT domain dimer of ACC is similar 
to the β2 dimer of PCC, the α2β2 assembly of PCC might be a plausible model for the 
organization of the ACC dimer, the protomer that can also form higher oligomers. This 
model implies that the BC domain could be monomeric in the ACC holoenzyme, which is 
consistent with observations that isolated BC domains of eukaryotic ACCs are monomeric 
in solution 28,29, in contrast to the dimers for bacterial BC subunits. Therefore, there might 
be a fundamental difference between the overall architecture of eukaryotic, multi-domain 
ACCs and that of bacterial, multi-subunit ACCs.
Methods summary
Crystallography
The α and β subunits of PCC were co-expressed in E. coli, with a His-tag on the β subunit. 
The PCC holoenzyme was purified by nickel affinity and gel filtration chromatography. 
Crystals were obtained by the microbatch method under oil, and the structures were 
determined by the molecular replacement method.
Cryo-electron microscopy
Frozen hydrated human PCC particles at 70 μg/ml concentration were imaged at 50,000× 
magnification in a 100 kV cryo-electron microscope. A featureless Gaussian oval was used 
to obtain a low resolution (40 Å) model from negative stain electron microscope images. A 
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15 Å resolution 3D reconstruction was obtained from ~10,000 cryo-EM particle images, 
using the structure from the negative stain images as the initial model.
Mutagenesis and kinetic studies
Site-specific and deletion mutants were designed based on the structural information, and 
their effects on the formation of the holoenzyme was assessed by nickel affinity 
chromatography. The catalytic activity of PCC was determined by a coupled enzyme assay, 
monitoring the hydrolysis of ATP.
Full Methods and any associated references are available in the online version of the paper 
at www.nature.com/nature.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Structure of the PCC holoenzyme
(a). Schematic drawing of the structure of the RpPCCα-RdPCCβ chimera, viewed down the 
three-fold symmetry axis. Domains in the α and β subunits in the top half of the structure are 
given different colors, and those in the first α and β subunits are labeled. The α and β 
subunits in the bottom half are colored in magenta and green, respectively. The red arrow 
indicates the viewing direction of panel b. (b). Structure of the RpPCCα-RdPCCβ chimera, 
viewed down the two-fold symmetry axis. The red rectangle indicates the region shown in 
detail in Fig. 2a. (c). Cryo-EM reconstruction of HsPCC at 15 Å resolution, viewed in the 
same orientation as panel a. The atomic model of the chimera was fit into the cryo-EM 
envelope. (d). The cryo-EM reconstruction viewed in the same orientation as panel b. The 
arrows indicate a change in the BCCP position that is needed to fit the cryo-EM map. All the 
structure figures were produced with PyMOL (www.pymol.org), and the cryo-EM figures 
were produced with Chimera 30.
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Figure 2. Interactions between the α and β subunits in the PCC holoenzyme
(a). Schematic drawing of the interface between the α and β subunits in the RpPCCα-
RdPCCβ chimera. (b). Detailed interactions between the hook in the BT domain of the α 
subunit and the β subunits. The C-terminal helix (α8) of an adjacent β subunit (labeled β2) is 
also shown. (c). Detailed interactions between helix αW in the BT domain and the β subunit. 
The view is related to that of panel a through a 90° rotation around the vertical axis. See 
Supplementary Fig. 8 for stereo versions of panels b and c.
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Figure 3. The active sites of the PCC holoenzyme
(a). Schematic drawing of the relative positioning of the BC and CT active sites in the 
holoenzyme. One α subunit and a β2 dimer (β1 from one layer and β4 from the other layer) 
are shown, and the viewing direction is the same as Fig. 1b. The two active sites are 
indicated with the stars, separated by 55 Å distance. The bound positions of ADP in 
complex with E. coli BC 18 and that of CoA in complex with the 12S subunit of 
transcarboxylase 21 are also shown. (b). Detailed interactions between BCCP-biotin and the 
C domain of a β subunit. Hydrogen-bonding interactions are indicated with the dashed lines 
in red. The N1′ atom of biotin is labeled as 1′, hydrogen-bonded to the main-chain carbonyl 
of Phe397. (c). Molecular surface of the CT active site, showing a deep canyon where both 
substrates are bound. (d). Schematic drawing of the CT active site. See Supplementary Fig. 
14 for stereo versions of panels b and d.
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Figure 4. Locations of disease-causing mutations in the PCC holoenzyme
Schematic drawing of the structure of one α subunit and one β2 subunit dimer of PCC, in the 
same view as Fig. 3a. The locations of the missense mutations associated with PA are 
indicated with the spheres, colored by the domains. The BC and CT active sites are indicated 
with the stars.
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